Medicine and Dentistry
Myofibroblast
100%
Kidney
100%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
100%
Ribonucleoside
100%
Ureter Obstruction
45%
Fibrosis
27%
In Vitro
18%
Surgery
18%
Fibroblast
18%
Scleroprotein
18%
Cells
9%
Therapeutic Procedure
9%
Signal Transduction
9%
Analysis
9%
Tissues
9%
Small Interfering RNA
9%
Male
9%
Combination Therapy
9%
down Regulation
9%
Mitogen Activated Protein Kinase 3
9%
Stimulation
9%
Chronic Kidney Disease
9%
Incubation
9%
Fibronectin
9%
Collagen Type 1
9%
Kidney Fibrosis
9%
Smooth Muscle Actin
9%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase Activator
9%
Biochemistry, Genetics and Molecular Biology
Kinase
100%
Agonist
100%
Myofibroblast
100%
Ribonucleoside
100%
Mouse
18%
Fibroblast
18%
Extracellular Matrix Proteins
18%
down Regulation
9%
Signal Transduction
9%
Rat
9%
Actin
9%
Mouse Model
9%
Small Interfering RNA
9%
STAT3
9%
In Vitro Study
9%
Bagg Albino Mouse
9%
Fibronectin
9%
Type I Collagen
9%
Pharmacology, Toxicology and Pharmaceutical Science
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
100%
Ribonucleoside
100%
Ureter Obstruction
45%
Fibrosis
27%
Mouse
18%
Scleroprotein
18%
Rat
9%
Mitogen Activated Protein Kinase 3
9%
Small Interfering RNA
9%
Chronic Kidney Failure
9%
Mouse Model
9%
Bagg Albino Mouse
9%
Collagen Type 1
9%
Smooth Muscle Actin
9%
Fibronectin
9%
Kidney Fibrosis
9%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase Activator
9%